Monopar Therapeutics Market Sentiment

SPY779.80+0.23%QQQ743.72+0.02%BTC/USD83,372.71+0.33%DIA518.40+0.42%GLD379.85−0.48%TLT78.58+0.27%

Premium

Monopar Therapeutics Inc

MNPRNASDAQ

Trade with Public

$72.08

-4.97-6.45%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Stock Report

Monopar Therapeutics Market Sentiment - Benzinga

Monopar Therapeutics Market Sentiment

Market sentiment signals for Monopar Therapeutics (MNPR): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 23.7% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

16 analysts

Options Flow (P/C)

—

Avg Consensus PT

$98

+35.4%

Highest Price Target

$145

+101.4%

Barclays

Lowest Price Target

$10

-86.1%

JonesTrading

Short Interest

23.7%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 11, 2026	Barclays	Etzer Darout—	+101.4%	$128 → $145	Maintained	Overweight
Aug 13, 2026	Barclays	Etzer Darout—	+77.8%	$125 → $128	Maintained	Overweight
Aug 13, 2026	Cantor Fitzgerald	Kristen Kluska—	+65.3%	$109 → $119	Downgrade	Overweight→Neutral
Aug 12, 2026	BTIG	Jeet Mukherjee —	+84.7%	$117 → $133	Maintained	Buy
Jul 22, 2026	HC Wainwright & Co.	Andres Y. Maldonado—	+73.6%	$105 → $125	Maintained	Buy
Jun 30, 2026	BTIG	Jeet Mukherjee —	+62.5%	$104 → $117	Maintained	Buy
Jun 29, 2026	HC Wainwright & Co.	Andres Y. Maldonado—	+45.8%	$105 → $105	Maintained	Buy
Mar 30, 2026	Chardan Capital	Keay Nakae—	+38.9%	$100 → $100	Maintained	Buy
Feb 23, 2026	BTIG	Jeet Mukherjee —	+44.4%	$104 → $104	Maintained	Buy
Feb 2, 2026	BTIG	Jeet Mukherjee —	+44.4%	$104 → $104	Maintained	Buy
Jan 29, 2026	Chardan Capital	Keay Nakae—	+38.9%	$100 → $100	Maintained	Buy
Jan 14, 2026	BTIG	Jeet Mukherjee —	+44.4%	$104 → $104	Maintained	Buy
Jan 9, 2026	Morgan Stanley	Maxwell Skor—	+59.7%	$115	Initiate	Overweight
Nov 14, 2025	Raymond James	Chris Raymond—	+70.8%	$142 → $123	Downgrade	Strong Buy→Outperform
Nov 13, 2025	Chardan Capital	Keay Nakae—	+38.9%	$100 → $100	Maintained	Buy
Nov 10, 2025	Leerink Partners	Joseph Schwartz—	+59.7%	$115	Initiate	Outperform
Nov 9, 2025	Chardan Capital	Keay Nakae—	+38.9%	$85 → $100	Maintained	Buy
Oct 13, 2025	Barclays	Etzer Darout—	+73.6%	$125	Initiate	Overweight
Oct 6, 2025	Raymond James	Chris Raymond—	+97.2%	$80 → $142	Maintained	Strong Buy
Oct 2, 2025	Oppenheimer	Andreas Argyrides—	+59.7%	$77 → $115	Maintained	Outperform
Sep 29, 2025	HC Wainwright & Co.	Andres Y. Maldonado—	+45.8%	$70 → $105	Maintained	Buy
Sep 25, 2025	Piper Sandler	Biren Amin—	+31.9%	$76 → $95	Maintained	Overweight
Sep 25, 2025	BTIG	Jeet Mukherjee —	+44.4%	$87 → $104	Maintained	Buy
Sep 25, 2025	Chardan Capital	Keay Nakae—	+18.0%	$60 → $85	Maintained	Buy
Sep 23, 2025	Lake Street	Chad Messer—	+47.2%	$106	Initiate	Buy